| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.00082 | 1 |